RNA EXTRACTION · SAMPLE HANDLING
RNA Degradation: What Happens Before Extraction Matters Most
Low RNA integrity often begins at collection, transport or storage rather than at the purification step. Learn how to trace preanalytical risks and decide what RNA QC is actually meaningful.
At the bench: RNA extraction cannot reconstruct molecules already degraded during collection or storage. Stabilise the sample using a method compatible with its matrix and downstream assay, then assess both RNA quantity and fragment integrity.
Why sample history matters
RNA is vulnerable to endogenous and environmental ribonucleases, and many specimen types begin changing soon after collection. Delayed processing, variable transport temperatures, incomplete penetration of a stabilising reagent or repeated thawing can produce inconsistent RNA integrity even when an extraction kit is used exactly as intended.
The aim is not merely to recover detectable RNA. For gene-expression studies, preanalytical changes can alter the relative abundance of transcripts, potentially creating biological-looking differences that reflect collection conditions instead. Record the timeline before using an extraction result to interpret a biological sample.
Follow the sample from collection to lysis
| Stage | Common risk | Good practice |
|---|---|---|
| Collection | Delay before stabilisation and continued cellular activity | Plan specimen-specific stabilisation or immediate processing in advance |
| Transport | Temperature excursions and prolonged transit | Use the transport conditions specified for that specimen and medium; record deviations |
| Storage | Repeated freeze-thaw or unsuitable time and temperature | Use compatible conditions and aliquots where appropriate |
| Homogenisation | Incomplete disruption or localised RNase activity | Follow a sample-specific disruption and lysis method |
| Purification and elution | RNase contamination or residual inhibitors | Use clean consumables, suitable controls and the kit’s recommended handling |
| Post-extraction | Excessive handling or inappropriate storage | Minimise exposure; record storage and intended assay |
RNase control is more than wearing gloves
Wear clean gloves and change them frequently, use certified RNase-free tips and tubes and clean reusable equipment appropriately. Some RNases are resilient, so an apparently tidy bench is not necessarily a suitable RNA work area. Keep RNA procedures away from deliberate RNase work where practicable and avoid repeatedly opening shared stocks.
For tissue samples, disruption conditions depend strongly on matrix type and the collection method. Frozen tissue should generally remain frozen until the prescribed disruption or lysis stage. Stabilising solutions require adequate contact with the specimen and must be compatible with the downstream extraction. Do not substitute a preservative or impose a universal temperature regime without checking the method.
RIN, DV200 and why concentration is not enough
RNA concentration indicates quantity, not molecule length or expression fidelity. Capillary electrophoresis systems may report an RNA integrity number (RIN) or similar metric that primarily reflects ribosomal RNA profiles. This can help compare conventional total-RNA preparations, but it is not a universal predictor of transcript integrity, especially for low-input, fixed or highly degraded specimens.
DV200 describes the percentage of RNA fragments longer than 200 nucleotides. This may be more informative for degraded samples used in certain sequencing library preparations. Neither a single RIN nor DV200 threshold is valid for every RT-qPCR or RNA-seq assay. Follow the specific library or amplification protocol and consider the target’s length and location.
For an example of why a sample can be abundant yet unsuitable for its intended assay, see the related DNA QC article. The broader principle, distinguishing quantity, purity and integrity, also applies to RNA even though the appropriate assays differ.
When RNA results are inconsistent: a root-cause table
| Observation | Possible source | What to check |
|---|---|---|
| High yield but degraded RNA | Damage before or during collection, or nuclease exposure | Review collection timeline and fragment profile |
| Different integrity between similar specimens | Transport, handling or tissue heterogeneity | Compare matched metadata and stabilisation procedures |
| Weak RT-qPCR despite sufficient RNA | Degradation, inhibitors, reverse-transcription or assay problems | Review controls, target design and relevant QC |
| Unexpected genomic DNA signal | DNA carryover or assay-design issues | Assess no-RT control and target-specific design |
| Low measured concentration | Low input, poor disruption, recovery loss or quantification error | Verify input, method range and mass balance |
A sample-receipt checklist for RNA laboratories
- Identify specimen type, intended downstream assay and stabilisation method.
- Record collection date/time, time to stabilisation, transport and storage conditions.
- Document visible specimen changes and any deviations before extraction.
- Confirm disruption and extraction methods are compatible with the sample matrix.
- Use appropriate extraction negatives and downstream assay controls.
- Assess quantity and integrity with a method that answers the actual assay question.
- Record whether the sample meets the downstream method’s acceptance criteria, rather than applying a universal RIN rule.
For compromised material, a shorter-target assay or a different library preparation may be appropriate, but these choices require evaluation. No cleanup procedure can reliably reconstruct RNA already lost from a specimen.
Which Gene Vantage workflow should you consider?
Gene Vantage has RNA purification products covering different sample and workflow categories. Browse the RNA extraction product category and choose according to the actual specimen, intended use and listed product grade. Contact the technical team for advice about challenging sample preparation, especially when collection and transport conditions are variable.
A suitable extraction kit can help manage sample processing, but it cannot compensate for every upstream specimen-quality problem. For any clinical or diagnostic application, confirm the product’s stated intended use and applicable regulatory grade.
Frequently asked questions
Can high RNA concentration mean good RNA integrity?
No. Concentration does not reveal whether the molecules are fragmented.
Must every RNA sample have RIN above 7?
No. Acceptance criteria depend on the assay and library preparation. Some methods are designed for degraded RNA.
Can freezing rescue RNA after a long delay?
Freezing can limit further degradation under suitable conditions, but does not reverse damage already incurred.
Is an RNA stabiliser compatible with every extraction kit?
No. Confirm specimen, stabiliser and purification-method compatibility.
What is the most useful information to collect when RNA results vary?
Detailed specimen history, timing, stabilisation and storage records, followed by appropriately selected RNA QC and downstream controls.
References and further reading
- Technical reference: RNA isolation best practices
- Technical reference: RNA stabilisation and specimen handling
- Technical reference: RNA QC and DV200 guidance
- Research: degraded FFPE RNA workflow considerations
Source material informs general scientific principles. Follow the latest product instructions and laboratory requirements for the specific specimen and assay.